Link to Genecards: | CLTCL | ALK |
ChimerKB | Top |
ChimerPUB | Top |
Fusion_pair | Translocation | PMID | Disease | Validation | Gene Type | Sentence_highlight |
---|---|---|---|---|---|---|
CLTCL_ALK | t(2;5)(p23;q35) / t(2;17)(p23;q25) / t(2;11;2)(p23;p15;q31) / | 12112524 | anaplastic large cell lymphoma;lymphoma | - | - | While most of the ALK-positive ALCL (ALKomas) are characterized by the presence of the NPM-ALK fusion protein, the product of the t(2;5)(p23;q35), 10-20% of ALKomas contain variant ALK fusions, including ATIC-ALK, TFG-ALK, CLTC-ALK (previously designated CLTCL-ALK), TMP3-ALK, and MSN-ALK. |
CLTCL_ALK | p23;q35 / t(1;2)(q25;p23) / t(2;3)(p23;q21) / | 10807789 | lymphoma | - | - | The CLTCL gene is constitutively expressed in lymphoid cells and therefore presumably contributes an active promoter for the CLTCL-ALK gene. |
ChimerSEQ | Top |
ChiTaRS 2.1 | Top |
FARE-CAFE | Top |
TicDB | Top |
TUMOR FUSION Gene Data Portal | Top |
FusionCancer | Top |
ConjoinG | Top |
1000Genome | Top |
18Cancers | Top |
Bodymap2 | Top |
HPA | Top |
Non_Tumor_Cells | Top |
Babiceanu_Dataset | Top |
Banned_Dataset | Top |
Known_Fusions | Top |
ONGene Database | Top |
Bushman Cancer Gene Database | Top |
Tumor Gene Set By Uniprot | Top |
Oesophagus_Dataset | Top |
Gliomas_Dataset | Top |
Prostate_Dataset | Top |
Pancreases_Dataset | Top |
GTEx | Top |
Klijin_Dataset | Top |
Fimereli_Dataset | Top |
Literature | Top |
Cortex_Dataset | Top |
ChromothripsisDB | Top |